share_log

TD Cowen Reiterates Buy on Hims & Hers Health, Maintains $28 Price Target

Benzinga ·  Nov 20 23:38  · Ratings

TD Cowen analyst Jonna Kim reiterates Hims & Hers Health (NYSE:HIMS) with a Buy and maintains $28 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment